{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T05:45:14Z","timestamp":1781588714205,"version":"3.54.5"},"reference-count":53,"publisher":"Bentham Science Publishers Ltd.","issue":"36","funder":[{"DOI":"10.13039\/501100004621","name":"Kerman University of Medical Sciences, Kerman, Iran","doi-asserted-by":"publisher","award":["KMU.AC.IR. 400001168"],"award-info":[{"award-number":["KMU.AC.IR. 400001168"]}],"id":[{"id":"10.13039\/501100004621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Parkinson's disease (PD) is a multifaceted disease that is influenced\nby both genetic and environmental parameters. Non-coding RNAs have been\nshown to be ideal biomarkers for several diseases, including PD. This study was conducted\nto evaluate the expression levels of NEAT1, hsa-let-7a-5p, and miR-506-3p in individuals\nwith PD to assess their efficacy for early-stage PD diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Twenty-four patients with PD and 29 healthy individuals participated in this\nstudy. The IntaRNA tool was used to predict potential base pairings between NEAT1\nand let-7a-5p, and NEAT1 and miR-506-3p. RT-qPCR was employed to measure the relative\nexpression of tyrosine hydroxylase (TH), as well as nuclear enriched abundant transcript\n1 (NEAT1), hsa-let-7a-5p, and miR-506-3p levels in both groups. The area under\nthe receiver operating characteristic curve (AUC) was calculated to evaluate the diagnostic\nvalue.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The PD group exhibited significantly elevated NEAT1 expression levels compared\nto the healthy control group. While the PD group exhibited an insignificant decreased\nTH expression level relative to the healthy group. Furthermore, the levels of\nhsa-let-7a-5p and miR-506-3p expression were seen to be decreased in patients with PD\nin comparison to the control group. Integration of NEAT1, hsa-let-7a-5p, and\nmiR-506-3p levels significantly enhanced diagnostic capabilities and increased the AUC\nto 0.9501 (95% confidence interval: 0.8978-1.000, p &lt; .0001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The elevated NEAT1 expression and the decreased expression of hsalet-\n7a-5p and miR-506-3p in PD patients indicate that these factors might contribute to\nthe disease's pathogenesis. Combining the ROC curves of NEAT1 and hsa-let-7a-5p\nwith miR-506-3p showed improved sensitivity and specificity, facilitating more accurate\nPD diagnosis. More importantly, they may contribute as promising non-invasive biomarkers\nfor PD diagnosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0109298673336756241016063552","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T06:31:14Z","timestamp":1730442674000},"page":"8214-8228","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Diagnostic Potential of NEAT1, hsa-let-7a-5p, and miR-506-3p in Early-stage Parkinson's Disease"],"prefix":"10.2174","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1234-7904","authenticated-orcid":true,"given":"Ali","family":"Samareh","sequence":"first","affiliation":[{"name":"Applied Cellular and Molecular Research Center, Kerman University of Medical Sciences, Kerman, Iran"},{"name":"Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences,Kerman, Iran"},{"name":"Department of Clinical Biochemistry, School of Medicine, Kerman University of MedicalSciences, Kerman, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hadi","family":"Nematollahi","sequence":"additional","affiliation":[{"name":"Applied Cellular and Molecular Research Center, Kerman University of Medical Sciences, Kerman, Iran"},{"name":"Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences,Kerman, Iran"},{"name":"Department of Clinical Biochemistry, School of Medicine, Kerman University of MedicalSciences, Kerman, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Pourghadamyari","sequence":"additional","affiliation":[{"name":"Applied Cellular and Molecular Research Center, Kerman University of Medical Sciences, Kerman, Iran"},{"name":"Department of Clinical Biochemistry, School of Medicine, Kerman University of MedicalSciences, Kerman, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein Ali Ebrahimi","family":"Meimand","sequence":"additional","affiliation":[{"name":"Neurology Research Center, Kerman University of Medical Sciences, Kerman,Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Shabani","sequence":"additional","affiliation":[{"name":"Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences,Kerman, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Asadikaram","sequence":"additional","affiliation":[{"name":"Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences,Kerman, Iran"},{"name":"Department of Clinical Biochemistry, School of Medicine, Kerman University of MedicalSciences, Kerman, Iran"},{"name":"Endocrinology and Metabolism Research Center, Institute of Basic and Clinical Physiology Sciences,Kerman, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1111\/ejn.14328","volume":"49","author":"Cabeleira M.E.P.","year":"2019","unstructured":"Cabeleira M.E.P.; Pagnussat A.S.; do Pinho A.S.; Asquidamini A.C.D.; Freire A.B.; Pereira B.T.; de Mello Rieder C.R.; Schifino G.P.; Fornari L.H.T.; Junior N.S.; Corr\u00eaa P.S.; Cechetti F.; Impairments in gait kinematics and postural control may not correlate with dopamine transporter depletion in individuals with mild to moderate Parkinson\u2019s disease. Eur J Neurosci  2019,49(12),1640-1648","journal-title":"Eur J Neurosci"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"24715492231162302","DOI":"10.1177\/24715492231162302","volume":"7","author":"Carroll P.J.","year":"2023","unstructured":"Carroll P.J.; Sheth U.; Henry P.; A systematic review of shoulder arthroplasty in Parkinson\u2019s Disease. J Shoulder Elb Arthroplast  2023,7,24715492231162302","journal-title":"J Shoulder Elb Arthroplast"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"9799","DOI":"10.1523\/JNEUROSCI.1787-16.2017","volume":"37","author":"Surmeier D.J.","year":"2017","unstructured":"Surmeier D.J.; Obeso J.A.; Halliday G.M.; Parkinson\u2019s disease is not simply a prion disorder. J Neurosci  2017,37(41),9799-9807","journal-title":"J Neurosci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"Poewe W.","year":"2017","unstructured":"Poewe W.; Seppi K.; Tanner C.M.; Halliday G.M.; Brundin P.; Volkmann J.; Schrag A.E.; Lang A.E.; Parkinson disease. Nat Rev Dis Primers  2017,3(1),17013","journal-title":"Nat Rev Dis Primers"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.18632\/aging.202378","volume":"13","author":"Zhou Q.","year":"2021","unstructured":"Zhou Q.; Zhang M.M.; Liu M.; Tan Z.G.; Qin Q.L.; Jiang Y.G.; LncRNA XIST sponges miR-199a-3p to modulate the Sp1\/LRRK2 signal pathway to accelerate Parkinson\u2019s disease progression. Aging (Albany NY)  2021,13(3),4115-4137","journal-title":"Aging (Albany NY)"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00702-022-02488-3","volume":"129","author":"Rausch W.D.","year":"2022","unstructured":"Rausch W.D.; Wang F.; Radad K.; From the tyrosine hydroxylase hypothesis of Parkinson\u2019s disease to modern strategies: a short historical overview. J Neural Transm (Vienna)  2022,129(5-6),487-495","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"350","DOI":"10.2174\/187152712800792901","volume":"11","author":"Zhu Y.","year":"2012","unstructured":"Zhu Y.; Zhang J.; Zeng Y.; Overview of tyrosine hydroxylase in Parkinson's disease. CNS Neurolog Disord Drug Targ  2012,11(4),350-358","journal-title":"CNS Neurolog Disord Drug Targ"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"Statello L.","year":"2021","unstructured":"Statello L.; Guo C.J.; Chen L.L.; Huarte M.; Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol  2021,22(2),96-118","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.humimm.2021.02.012","volume":"82","author":"Hu T.","year":"2021","unstructured":"Hu T.; Chitnis N.; Monos D.; Dinh A.; Next-generation sequencing technologies: An overview. Hum Immunol  2021,82(11),801-811","journal-title":"Hum Immunol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00335-021-09901-4","volume":"33","author":"Grammatikakis I.","year":"2022","unstructured":"Grammatikakis I.; Lal A.; Significance of lncRNA abundance to function. Mamm Genome  2022,33(2),271-280","journal-title":"Mamm Genome"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-16-2634","volume":"77","author":"Bhan A.","year":"2017","unstructured":"Bhan A.; Soleimani M.; Mandal S.S.; Long noncoding RNA and cancer: a new paradigm. Cancer Res  2017,77(15),3965-3981","journal-title":"Cancer Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3390\/ijms21031027","volume":"21","author":"Kazimierczyk M.","year":"2020","unstructured":"Kazimierczyk M.; Kasprowicz M.K.; Kasprzyk M.E.; Wrzesinski J.; Human long noncoding RNA interactome: detection, characterization and function. Int J Mol Sci  2020,21(3),1027","journal-title":"Int J Mol Sci"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3389\/fgene.2018.00744","volume":"9","author":"Li L.","year":"2019","unstructured":"Li L.; Zhuang Y.; Zhao X.; Li X.; Long non-coding RNA in neuronal development and neurological disorders. Front Genet  2019,9,744","journal-title":"Front Genet"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1080\/01616412.2018.1548747","volume":"41","author":"Zhao M.Y.","year":"2019","unstructured":"Zhao M.Y.; Wang G.Q.; Wang N.N.; Yu Q.Y.; Liu R.L.; Shi W.Q.; The long-non-coding RNA NEAT1 is a novel target for Alzheimer\u2019s disease progression via miR-124\/BACE1 axis. Neurol Res  2019,41(6),489-497","journal-title":"Neurol Res"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/s41556-018-0204-2","volume":"20","author":"Wang Y.","year":"2018","unstructured":"Wang Y.; Hu S.B.; Wang M.R.; Yao R.W.; Wu D.; Yang L.; Chen L.L.; Genome-wide screening of NEAT1 regulators reveals cross-regulation between paraspeckles and mitochondria. Nat Cell Biol  2018,20(10),1145-1158","journal-title":"Nat Cell Biol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"11223","DOI":"10.1096\/fj.201900830R","volume":"33","author":"Simchovitz A.","year":"2019","unstructured":"Simchovitz A.; Hanan M.; Niederhoffer N.; Madrer N.; Yayon N.; Bennett E.R.; Greenberg D.S.; Kadener S.; Soreq H.; NEAT1 is overexpressed in Parkinson\u2019s disease substantia nigra and confers drug-inducible neuroprotection from oxidative stress. FASEB J  2019,33(10),11223-11234","journal-title":"FASEB J"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"e10172","DOI":"10.1002\/btm2.10172","volume":"5","author":"Born L.J.","year":"2020","unstructured":"Born L.J.; Harmon J.W.; Jay S.M.; Therapeutic potential of extracellular vesicle-associated long noncoding RNA. Bioeng Transl Med  2020,5(3),e10172","journal-title":"Bioeng Transl Med"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fnmol.2020.00160","volume":"13","author":"Wei W.","year":"2020","unstructured":"Wei W.; Wang Z.Y.; Ma L.N.; Zhang T.T.; Cao Y.; Li H.; Ma L-N, Zhang T-T, Cao Y, Li H. MicroRNAs in Alzheimer\u2019s disease: function and potential applications as diagnostic biomarkers. Front Mol Neurosci  2020,13,160","journal-title":"Front Mol Neurosci"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"104417","DOI":"10.1016\/j.meegid.2020.104417","volume":"85","author":"Guterres A.","year":"2020","unstructured":"Guterres A.; de Azeredo Lima C.H.; Miranda R.L.; Gadelha M.R.; What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19? Infect Genet Evol  2020,85,104417","journal-title":"Infect Genet Evol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/ncrna6040042","volume":"6","author":"Teppan J.","year":"2020","unstructured":"Teppan J.; Barth D.A.; Prinz F.; Jonas K.; Pichler M.; Klec C.; Involvement of long non-coding RNAs (lncRNAs) in tumor angiogenesis. Noncoding RNA  2020,6(4),42","journal-title":"Noncoding RNA"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-1-62703-748-8_2","volume":"1107","author":"T\u00fcfekci K.U.","year":"2014","unstructured":"T\u00fcfekci K.U.; Meuwissen R.L.J.; Gen\u00e7 \u015e.; The role of microRNAs in biological processes. Methods Mol Biol  2014,1107,15-31","journal-title":"Methods Mol Biol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"e22867","DOI":"10.1002\/jbt.22867","volume":"35","author":"Zhang H.","year":"2021","unstructured":"Zhang H.; Wang Z.; Hu K.; Liu H.; Downregulation of long noncoding RNA SNHG7 protects against inflammation and apoptosis in Parkinson\u2019s disease model by targeting the miR-425-5p\/TRAF5\/NF-\u03baB axis. J Biochem Mol Toxicol  2021,35(10),e22867","journal-title":"J Biochem Mol Toxicol"},{"key":"ref=23","first-page":"243","author":"Karagkouni D.","year":"2021","unstructured":"Karagkouni D.; Karavangeli A.; Paraskevopoulou M.D.; Hatzigeorgiou A.G.; Characterizing miRNA\u2013lncRNA interplay. Long non-coding RNAs. Methods Protoc  2021,243-262","journal-title":"Methods Protoc"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"17779","DOI":"10.1002\/jcb.29045","volume":"120","author":"Ma H.","year":"2019","unstructured":"Ma H.; Wang L.Y.; Yang R.H.; Zhou Y.; Zhou P.; Kong L.; Identification of reciprocal microRNA-mRNA pairs associated with metastatic potential disparities in human prostate cancer cells and signaling pathway analysis. J Cell Biochem  2019,120(10),17779-17790","journal-title":"J Cell Biochem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s12031-017-0926-9","volume":"62","author":"Schwienbacher C.","year":"2017","unstructured":"Schwienbacher C.; Foco L.; Picard A.; Corradi E.; Serafin A.; Panzer J.; Zanigni S.; Blankenburg H.; Facheris M.F.; Giannini G.; Falla M.; Cortelli P.; Pramstaller P.P.; Hicks A.A.; Plasma and white blood cells show different miRNA expression profiles in Parkinson\u2019s disease. J Mol Neurosci  2017,62(2),244-254","journal-title":"J Mol Neurosci"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-015-0524-9","volume":"16","author":"Santos-Garc\u00eda D.","year":"2016","unstructured":"Santos-Garc\u00eda D.; Mir P.; Cubo E.; Vela L.; Rodr\u00edguez-Oroz M.C.; Mart\u00ed M.J.; COPPADIS-2015 (COhort of Patients with PArkinson\u2019s DIsease in Spain, 2015), a global\u2013clinical evaluations, serum biomarkers, genetic studies and neuroimaging\u2013prospective, multicenter, non-interventional, long-term study on Parkinson\u2019s disease progression. BMC Neurol  2016,16,1-14","journal-title":"BMC Neurol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"W119","DOI":"10.1093\/nar\/gku359","volume":"42","author":"Wright P.R.","year":"2014","unstructured":"Wright P.R.; Georg J.; Mann M.; Sorescu D.A.; Richter A.S.; Lott S.; Kleinkauf R.; Hess W.R.; Backofen R.; CopraRNA and IntaRNA: predicting small RNA targets, networks and interaction domains. Nucleic Acids Res  2014,42(W1),W119-W123","journal-title":"Nucleic Acids Res"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"Livak K.J.","year":"2001","unstructured":"Livak K.J.; Schmittgen T.D.; Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394CT method. Methods  2001,25(4),402-408","journal-title":"Methods"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3238\/arztebl.2016.0061","volume":"113","author":"Levin J.","year":"2016","unstructured":"Levin J.; Kurz A.; Arzberger T.; Giese A.; H\u00f6glinger G.U.; The differential diagnosis and treatment of atypical parkinsonism. Dtsch Arztebl Int  2016,113(5),61-69","journal-title":"Dtsch Arztebl Int"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.1007\/s12035-016-0038-5","volume":"54","author":"Yang B.","year":"2017","unstructured":"Yang B.; Xia Z.; Zhong B.; Xiong X.; Sheng C.; Wang Y.; Gong W.; Cao Y.; Wang Z.; Peng W.; Distinct hippocampal expression profiles of long non-coding RNAs in an Alzheimer\u2019s disease model. Mol Neurobiol  2017,54(7),4833-4846","journal-title":"Mol Neurobiol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"598606","DOI":"10.3389\/fnagi.2020.598606","volume":"12","author":"Huaying C.","year":"2021","unstructured":"Huaying C.; Xing J.; Luya J.; Linhui N.; Di S.; Xianjun D.; A signature of five long non-coding RNAs for predicting the prognosis of Alzheimer\u2019s disease based on competing endogenous RNA networks. Front Aging Neurosci  2021,12,598606","journal-title":"Front Aging Neurosci"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"e00941","DOI":"10.1002\/brb3.941","volume":"8","author":"Chen L.","year":"2018","unstructured":"Chen L.; Yang J.; L\u00fc J.; Cao S.; Zhao Q.; Yu Z.; Identification of aberrant circulating mi  s in Parkinson\u2019s disease plasma samples. Brain Behav  2018,8(4),e00941","journal-title":"Brain Behav"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"40127","DOI":"10.1038\/srep40127","volume":"7","author":"Barry G.","year":"2017","unstructured":"Barry G.; Briggs J.A.; Hwang D.W.; Nayler S.P.; Fortuna P.R.J.; Jonkhout N.; Dachet F.; Maag J.L.V.; Mestdagh P.; Singh E.M.; Avesson L.; Kaczorowski D.C.; Ozturk E.; Jones N.C.; Vetter I.; Arriola-Martinez L.; Hu J.; Franco G.R.; Warn V.M.; Gong A.; Dinger M.E.; Rigo F.; Lipovich L.; Morris M.J.; O\u2019Brien T.J.; Lee D.S.; Loeb J.A.; Blackshaw S.; Mattick J.S.; Wolvetang E.J.; The long non-coding RNA NEAT1 is responsive to neuronal activity and is associated with hyperexcitability states. Sci Rep  2017,7(1),40127","journal-title":"Sci Rep"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.2147\/OTT.S220306","volume":"13","author":"Shen X.","year":"2020","unstructured":"Shen X.; Zhao W.; Zhang Y.; Liang B.; Long non-coding RNA-NEAT1 promotes cell migration and invasion via regulating miR-124\/NF-\u03baB pathway in cervical cancer. OncoTargets Ther  2020,13,3265-3276","journal-title":"OncoTargets Ther"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12957-019-1767-5","volume":"18","author":"He K.","year":"2020","unstructured":"He K.; Zhu Z-B.; Shu R.; Hong A.; LncRNA NEAT1 mediates progression of oral squamous cell carcinoma via VEGF-A and Notch signaling pathway. World J Surg Oncol  2020,18(1),1-9","journal-title":"World J Surg Oncol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ncrna.2018.11.003","volume":"3","author":"An H.","year":"2018","unstructured":"An H.; Williams N.G.; Shelkovnikova T.A.; NEAT1 and paraspeckles in neurodegenerative diseases: A missing lnc found? Noncoding RNA Res  2018,3(4),243-252","journal-title":"Noncoding RNA Res"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.bbrc.2017.12.149","volume":"496","author":"Yan W.","year":"2018","unstructured":"Yan W.; Chen Z.Y.; Chen J.Q.; Chen H.M.; LncRNA NEAT1 promotes autophagy in MPTP-induced Parkinson\u2019s disease through stabilizing PINK1 protein. Biochem Biophys Res Commun  2018,496(4),1019-1024","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1111\/1440-1681.12932","volume":"45","author":"Liu Y.","year":"2018","unstructured":"Liu Y.; Lu Z.; Long non-coding  1 mediates the toxic of Parkinson\u2019s disease induced by  \/  + via regulation of gene expression. Clin Exp Pharmacol Physiol  2018,45(8),841-848","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"226","DOI":"10.55782\/ane-2022-021","volume":"82","author":"Zhao J.","year":"2022","unstructured":"Zhao J.; Wan X.N.; Zhu J.P.; Liu Q.C.; Gan L.; LncRNA NEAT1 promoted MPP+-induced ferroptosis via regulating miR-150-5p\/BAP1 pathway in SK-N-SH cells. Acta Neurobiol Exp (Warsz)  2022,82(2),226-236","journal-title":"Acta Neurobiol Exp (Warsz)"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"12261","DOI":"10.1080\/21655979.2022.2062989","volume":"13","author":"Dong L.","year":"2022","unstructured":"Dong L.; Zheng Y.; Luo X.; lncRNA NEAT1 promotes autophagy of neurons in mice by impairing miR-107-5p. Bioengineered  2022,13(5),12261-12274","journal-title":"Bioengineered"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"147156","DOI":"10.1016\/j.brainres.2020.147156","volume":"1750","author":"Zhou S.","year":"2021","unstructured":"Zhou S.; Zhang D.; Guo J.; Chen Z.; Chen Y.; Zhang J.; Deficiency of NEAT1 prevented MPP-induced inflammatory response, oxidative stress and apoptosis in dopaminergic SK-N-SH neuroblastoma cells via miR-1277-5p\/ARHGAP26 axis. Brain Res  2021,1750,147156","journal-title":"Brain Res"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s11064-020-03157-1","volume":"46","author":"Liu T.","year":"2021","unstructured":"Liu T.; Zhang Y.; Liu W.; Zhao J.; LncRNA NEAT1 regulates the development of Parkinson\u2019s disease by targeting AXIN1 via sponging miR-212-3p. Neurochem Res  2021,46(2),230-240","journal-title":"Neurochem Res"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1080\/21655979.2021.1883279","volume":"12","author":"Chen M.Y.","year":"2021","unstructured":"Chen M.Y.; Fan K.; Zhao L.J.; Wei J.M.; Gao J.X.; Li Z.F.; Long non-coding RNA nuclear enriched abundant transcript 1 (NEAT1) sponges microRNA-124-3p to up-regulate phosphodiesterase 4B (PDE4B) to accelerate the progression of Parkinson\u2019s disease. Bioengineered  2021,12(1),708-719","journal-title":"Bioengineered"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1016\/j.wneu.2021.08.147","volume":"156","author":"Wang S.","year":"2021","unstructured":"Wang S.; Wen Q.; Xiong B.; Zhang L.; Yu X.; Ouyang X.; Long noncoding RNA NEAT1 knockdown ameliorates 1-methyl-4-phenylpyridine\u2013induced cell injury through MicroRNA-519a-3p\/SP1 axis in Parkinson disease. World Neurosurg  2021,156,e93-e103","journal-title":"World Neurosurg"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1515\/biol-2020-0069","volume":"15","author":"Liu J.","year":"2020","unstructured":"Liu J.; Liu D.; Zhao B.; Jia C.; Lv Y.; Liao J.; Li K.; Long non-coding RNA NEAT1 mediates MPTP\/MPP-induced apoptosis via regulating the miR-124\/KLF4 axis in Parkinson\u2019s disease. Open Life Sci  2020,15(1),665-676","journal-title":"Open Life Sci"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ol.2021.13119","volume":"23","author":"Chen H.","year":"2021","unstructured":"Chen H.; Wang J.; Wang H.; Liang J.; Dong J.; Bai H.; Jiang G.; Advances in the application of Let-7 microRNAs in the diagnosis, treatment and prognosis of leukemia (Review). Oncol Lett  2021,23(1),1-8","journal-title":"Oncol Lett"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"e0221779","DOI":"10.1371\/journal.pone.0221779","volume":"15","author":"Fadhil R.S.","year":"2020","unstructured":"Fadhil R.S.; Wei M.Q.; Nikolarakos D.; Good D.; Nair R.G.; Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma. PLoS One  2020,15(3),e0221779","journal-title":"PLoS One"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"6913","DOI":"10.3892\/ol.2018.8181","volume":"15","author":"Chen W.","year":"2018","unstructured":"Chen W.; Lin G.; Yao Y.; Chen J.; Shui H.; Yang Q.; Wang X.; Weng X.; Sun L.; Chen F.; Yang S.; Yang Y.; Zhou Y.; MicroRNA hsa-let-7e-5p as a potential prognosis marker for rectal carcinoma with liver metastases. Oncol Lett  2018,15(5),6913-6924","journal-title":"Oncol Lett"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"850364","DOI":"10.3389\/fnmol.2022.850364","volume":"15","author":"Wang Y.","year":"2022","unstructured":"Wang Y.; Han T.; Guo R.; Song P.; Liu Y.; Wu Z.; Ai J.; Shen C.; Micro-RNA let-7a-5p derived from mesenchymal stem cell-derived extracellular vesicles promotes the regrowth of neurons in spinal-cord-injured rats by targeting the HMGA2\/SMAD2 Axis. Front Mol Neurosci  2022,15,850364","journal-title":"Front Mol Neurosci"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/ng1590","volume":"37","author":"Bentwich I.","year":"2005","unstructured":"Bentwich I.; Avniel A.; Karov Y.; Aharonov R.; Gilad S.; Barad O.; Barzilai A.; Einat P.; Einav U.; Meiri E.; Sharon E.; Spector Y.; Bentwich Z.; Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet  2005,37(7),766-770","journal-title":"Nat Genet"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/molbev\/msp284","volume":"27","author":"Li J.","year":"2010","unstructured":"Li J.; Liu Y.; Dong D.; Zhang Z.; Evolution of an X-linked primate-specific micro RNA cluster. Mol Biol Evol  2010,27(3),671-683","journal-title":"Mol Biol Evol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"62778","DOI":"10.18632\/oncotarget.11294","volume":"7","author":"Li J.","year":"2016","unstructured":"Li J.; Ju J.; Ni B.; Wang H.; The emerging role of miR-506 in cancer. Oncotarget  2016,7(38),62778-62788","journal-title":"Oncotarget"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.gene.2016.08.026","volume":"593","author":"Wang Y.","year":"2016","unstructured":"Wang Y.; Jiaqi C.; Zhaoying C.; Huimin C.; MicroRNA-506-3p regulates neural stem cell proliferation and differentiation through targeting TCF3. Gene  2016,593(1),193-200","journal-title":"Gene"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673336756241016063552","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/235962\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673336756241016063552","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T04:31:14Z","timestamp":1762403474000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/235962\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":53,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673336756241016063552","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-07-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}